Cardiovascular Diseases
Conditions
Keywords
cardiac disease, cerebrovascular disease, GH deficiency, diabetes mellitus, hypertension, GH therapy, GH deficiency and hypopituitarims
Brief summary
The aim of the present study was therefore two-fold: 1) to make a retrospective comparison of incidence of non-fatal stroke and cardiac events between a large cohort of patients with confirmed GHD on replacement therapy (including GH) and a control cohort from the general population; 2) to compare the prevalence of DM and cardioprotective medication between the cohorts at the time of questionnaire distribution with adjustment for possible confounders and effect modifiers.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Confirmed GH deficiency
Exclusion criteria
* Not confirmed GH deficiency